Cordium Pharmaceuticals Pvt Ltd is a leading India-based global pharmaceutical exporter, specializing in high-quality oncology medicines including Palbociclib 75 mg Capsules, widely used in advanced breast cancer treatment protocols across global healthcare markets.
We provide fast, reliable international pharmaceutical export supply with compliant packaging and secure logistics to major destinations:
🌍 South Africa: Johannesburg, Cape Town, Pretoria, Durban, Port Elizabeth (Gqeberha), Bloemfontein, KwaZulu-Natal (All Regions), East London, Nelspruit, Polokwane
🌍 USA: Washington, New York
🌍 UAE: Dubai, Abu Dhabi
🌍 UK: London
🌍 Asia: Singapore, Philippines
💊 Product Overview – Palbociclib 75 mg Capsules
Palbociclib is an oral targeted anti-cancer therapy classified as a CDK4/6 inhibitor, used in combination with endocrine treatments for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.
It works by slowing the progression of cancer cells and improving treatment outcomes under oncologist supervision.
🧪 Usage / Indications
- Treatment of HR+/HER2- advanced or metastatic breast cancer
- Used in combination with hormonal therapies (e.g., letrozole, fulvestrant)
- Helps control abnormal cell division in cancer progression
- Recommended as part of targeted oncology therapy protocols
💊 Dosage Information (General Clinical Guidance)
- Typically administered in 21 days on / 7 days off cycle
- Common strength regimen includes 125 mg daily standard dosing, while 75 mg capsules are used for:
- Dose reduction due to adverse effects
- Patient tolerance adjustment
- Clinical condition-specific modification
⚠️ Dosage must always be prescribed and monitored by a qualified oncologist. Self-medication is strictly not recommended.
⚠️ Side Effects
Possible side effects include:
- Neutropenia (low white blood cell count)
- Fatigue and weakness
- Nausea or vomiting
- Hair thinning or hair loss
- Diarrhea
- Reduced appetite
- Mouth sores
Serious (rare) effects:
- Severe infections
- Liver function abnormalities
- Lung inflammation (interstitial lung disease)
🚨 Precautions
- Regular blood test monitoring is essential
- Not recommended during pregnancy or breastfeeding
- Avoid interaction with strong CYP3A inhibitors/inducers
- Use only under oncology specialist supervision
- Inform physician about liver, kidney, or blood disorders
🌐 Cordium Pharmaceuticals Global Export Strength
Cordium Pharmaceuticals Pvt Ltd ensures:
✔ WHO-GMP compliant sourcing
✔ Secure cold-chain & ambient packaging options
✔ Fast international pharma logistics support
✔ Reliable supply to hospitals, distributors & licensed importers
✔ Strong global distribution network for oncology medicines
We are committed to delivering trusted oncology pharmaceutical exports from India to global markets with consistency and quality assurance.
📲 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
